Format

Send to

Choose Destination
J Neurol Sci. 2018 Apr 15;387:103-108. doi: 10.1016/j.jns.2018.01.025. Epub 2018 Jan 31.

Identification of a prospective early motor progression cluster of Parkinson's disease: Data from the PPMI study.

Author information

1
Department of Neurology, Athens Naval Hospital, Deinokratous, Athens 70, Greece. Electronic address: gvavou@med.uth.gr.
2
Department of Neurology, Athens Naval Hospital, Deinokratous, Athens 70, Greece.
3
1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Greece.
4
Statens Serum Institut, 5 Artillerivej, Copenhagen DK-2300, Denmark.
5
Department of Physiology, Faculty of Medicine, University of Thessaly, Biopolis, Larissa 41110, Greece.
6
Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens, Athens, Greece; Second Department of Neurology, National and Kapodistrian University of Athens Medical School, Athens, Greece.

Abstract

AIM:

The aim of our study is to phenotype PD motor progression, and to detect whether serum, cerebrospinal fluid (CSF), neuroimaging biomarkers and neuropsychological measures characterize PD motor progression phenotypes.

METHODS:

We defined motor progression as a difference of at least one point in the Hoehn & Yahr (H&Y) scale between the baseline (Visit 0, V0), 12 months (Visit 04, V04) and 36 months (Visit 08, V08) milestones of the Progression Markers Initiative (PPMI) study. H&Y progression events were recorded at each milestone in order to be used as cluster analysis variables, in order to produce progression phenotypes. Subsequently, cross-cluster comparisons prior to and following (pairwise) propensity score matching were performed in order to assess phenotype - defining characteristics.

RESULTS:

Four progression clusters where identified: SPPD: Secondarily Progressive PD, H&Y progression between V04 and V08; EPPD: Early Progressive PD. H&Y progression between V0 and V04; NPPD: Non Progressive PD, no H&Y progression; MIPD: Minimally Improving PD, i.e. Minimal H&Y improvement H&Y progression between V04 and V08;. Independent Samples Mann Whitney U tests determined CSF aSyn (p = 0.006, adj p-value = 0.036. I) and Semantic Animal fluency T-score (SFT, p = 0.003, adjusted p-value = 0.016.) as statistically significant cross-cluster characteristics. Following Propensity Score Matching, SFT, Hopkins Verbal Learning Test (Retention/Recall), Serum IGF1, CSF aSyn, DaT-SPECT binding ratios (SBRs) and the Benton Judgement of Line Orientation Test (BJLOT) were determined as statistically significant predictors of cluster differentiation (p < 0.05).

DISCUSSION:

SFT, Serum IGF1, CSF aSyn and DaT-SPECT-derived, basal ganglia Striatal Binding Ratios warrant further investigation as possible motor progression biomarkers.

KEYWORDS:

Biomarkers; Cluster analysis; Parkinson's disease; Phenotypes; Progression

PMID:
29571843
DOI:
10.1016/j.jns.2018.01.025

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center